Comments
Loading...
Pieris Pharmaceuticals (PIRS) Forecast
NewsEarningsPieris Pharmaceuticals (PIRS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPieris Pharmaceuticals (NASDAQ:PIRS) Stock Quotes, Forecast and News Summary
Pieris Pharmaceuticals Stock (NASDAQ: PIRS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Pieris Pharmaceuticals (PIRS) stock?
You can purchase shares of Pieris Pharmaceuticals (NASDAQ:PIRS) through any online brokerage.
Who are Pieris Pharmaceuticals (PIRS) competitors?
Other companies in Pieris Pharmaceuticals’s space includes: Acurx Pharmaceuticals (NASDAQ:ACXP), Nanoviricides (AMEX:NNVC), Bolt Biotherapeutics (NASDAQ:BOLT), Geovax Labs (NASDAQ:GOVX) and Palatin Techs (AMEX:PTN).
What is the forecast, or price target, for Pieris Pharmaceuticals (PIRS) stock?
There is no analysis for Pieris Pharmaceuticals to provide a consensus price target.
What is the current price for Pieris Pharmaceuticals (PIRS)?
The stock price for Pieris Pharmaceuticals (NASDAQ: PIRS) is $15.934 last updated November 21, 2024 at 1:51 PM EST.
Does Pieris Pharmaceuticals (PIRS) pay a dividend?
There are no upcoming dividends for Pieris Pharmaceuticals.
When is Pieris Pharmaceuticals (NASDAQ:PIRS) reporting earnings?
Pieris Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
Is Pieris Pharmaceuticals (PIRS) going to split?
There is no upcoming split for Pieris Pharmaceuticals.
What sector and industry does Pieris Pharmaceuticals (PIRS) operate in?
Pieris Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.